We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSHP Director/PDMR Shareholding December 14, 2018 -- Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities Details of the person discharging managerial responsibilities ("PDMR") / person closely 1. associated with them ("PCA") --- ----------------------------------------------------------------------- a) Name Bill Mordan --- -------------------------- ------------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------------- General Counsel and Company Secretary a) Position / status - PDMR --- -------------------------- ------------------------------------------- Initial notification b) / amendment Initial notification --- -------------------------- ------------------------------------------- Details of the issuer, emission allowance participant, auction platform, auctioneer 3. or auction monitor --- ----------------------------------------------------------------------- a) Name Shire plc --- -------------------------- ------------------------------------------- b) LEI 54930005LQRLI2UXRQ59 --- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 4. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 26, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 5. below.) --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 8,853 --- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) --- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 --- -------------------------- ------------------------------------------- Place of the f) transaction N/A --- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 5. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 3,983 --- -------------------------- ------------------ ------------------- d) Aggregated information N/A (single transaction) - Aggregated volume - Price --- -------------------------- ------------------------------------------- e) Date of the December 11, 2018 transaction --- -------------------------- ------------------------------------------- f) Place of the NASDAQ transaction --- -------------------------- ------------------------------------------- Details of the person discharging managerial responsibilities ("PDMR") / person closely 1. associated with them ("PCA") ---- ----------------------------------------------------------------------- a) Name Joanne Cordeiro ---- -------------------------- ------------------------------------------- 2. Reason for the notification ---- ----------------------------------------------------------------------- Chief Human Resources Officer a) Position / status -- PDMR ---- -------------------------- ------------------------------------------- Initial notification b) / amendment Initial notification ---- -------------------------- ------------------------------------------- Details of the issuer, emission allowance participant, auction platform, auctioneer 3. or auction monitor ---- ----------------------------------------------------------------------- a) Name Shire plc ---- -------------------------- ------------------------------------------- b) LEI 54930005LQRLI2UXRQ59 ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 4. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on May 1, 2018. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company
in respect of the PSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 5. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 12,050 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 5. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 5,420 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 6. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 26, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 7. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 494 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 7. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 224 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 8. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- -------------------------------------------
Receipt of ADSs following the vesting of Restricted Stock Units ("RSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on August 24, 2017. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP, vesting of the RSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 9. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 1,410 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 9. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 8. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the RSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 633 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 10. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Restricted Stock Units ("RSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 28, 2017. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP, vesting of the RSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 11. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 104 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 11. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 10. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the RSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 47 ---- -------------------------- ------------------ -------------------
Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 12. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Restricted Stock Units ("RSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 26, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP, vesting of the RSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 13. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 173 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 13. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 12. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the RSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 79 ---- -------------------------- ------------------ ------------------- d) Aggregated information N/A (single transaction) - Aggregated volume - Price ---- -------------------------- ------------------------------------------- e) Date of the December 11, 2018 transaction ---- -------------------------- ------------------------------------------- f) Place of the NASDAQ transaction ---- -------------------------- ------------------------------------------- Details of the person discharging managerial responsibilities ("PDMR") / person closely 1. associated with them ("PCA") ---- ----------------------------------------------------------------------- a) Name Perry Sternberg ---- -------------------------- ------------------------------------------- 2. Reason for the notification ---- ----------------------------------------------------------------------- a) Position / status Head of US Commercial - PDMR ---- -------------------------- ------------------------------------------- Initial notification b) / amendment Initial notification ---- -------------------------- ------------------------------------------- Details of the issuer, emission allowance participant, auction platform, auctioneer 3. or auction monitor ---- ----------------------------------------------------------------------- a) Name Shire plc ---- -------------------------- ------------------------------------------- b) LEI 54930005LQRLI2UXRQ59 ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 4. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Restricted Stock Units ("RSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on August 5, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP, vesting of the RSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 5. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 1,011 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction)
---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 5. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the RSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 388 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 6. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Restricted Stock Units ("RSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 26, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP, vesting of the RSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the RSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 7. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 441 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 7. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of RSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the RSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 133 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 8. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 26, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated
relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposals Nature of the of ADSs are referenced in sections b) transaction 10. and 11. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 1,260 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 9. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on February 28, 2017. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 87% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposals Nature of the of ADSs are referenced in sections b) transaction 10. and 11. below.) ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 7,790 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction N/A ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 10. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in sections 8 and 9. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 3,940 ---- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) ---- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 ---- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ ---- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 11. have been conducted ---- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") ---- Identification a) code ISIN: US82481R1068 ---- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in sections 8. and 9. above. The proceeds of this disposal were used to satisfy Nature of the personal tax liabilities arising b) transaction from the vesting of the PSUs. ---- -------------------------- ------------------------------------------- Price(s) Volume(s) ---- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 175.1500 91 ---- -------------------------- ------------------ ------------------- d) Aggregated information N/A (single transaction) - Aggregated volume - Price ---- -------------------------- ------------------------------------------- e) Date of the December 13, 2018 transaction ---- -------------------------- ------------------------------------------- f) Place of the NASDAQ transaction ---- -------------------------- ------------------------------------------- Details of the person discharging managerial responsibilities ("PDMR") / person closely 1. associated with them ("PCA")
--- ----------------------------------------------------------------------- a) Name Matt Walker --- -------------------------- ------------------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------------- Head of Technical Operations -- a) Position / status PDMR --- -------------------------- ------------------------------------------- Initial notification b) / amendment Initial notification --- -------------------------- ------------------------------------------- Details of the issuer, emission allowance participant, auction platform, auctioneer 3. or auction monitor --- ----------------------------------------------------------------------- a) Name Shire plc --- -------------------------- ------------------------------------------- b) LEI 54930005LQRLI2UXRQ59 --- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 4. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on May 1, 2018. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 5. below.) --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 12,665 --- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) --- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 --- -------------------------- ------------------------------------------- Place of the f) transaction N/A --- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 5. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 4. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 5,652 --- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) --- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 --- -------------------------- ------------------------------------------- Place of the f) transaction NASDAQ --- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 6. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Receipt of ADSs following the vesting of Performance Stock Units ("PSUs") awarded under the Shire Long Term Incentive Plan 2015 ("LTIP") on May 2, 2016. In accordance with: (i) the Co-Operation Agreement between the Company and Takeda Pharmaceutical Company Limited dated May 8, 2018, and the rules of the LTIP: a. 100% of the PSUs vested pursuant to applicable performance conditions; b. vesting of the PSUs was accelerated relative to the normal vesting date; and (ii) the rules of the LTIP, upon vesting the number of ADSs to be delivered was increased by an amount equivalent to the value of dividends paid by the Company in respect of the PSUs from the award date to the date of vesting. (Details of related disposal of Nature of the ADSs are referenced in section b) transaction 7. below.) --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 0 3,292 --- -------------------------- ------------------ ------------------- Aggregated information - Aggregated d) volume - Price N/A (single transaction) --- -------------------------- ------------------------------------------- Date of the e) transaction December 11, 2018 --- -------------------------- ------------------------------------------- Place of the f) transaction N/A
--- -------------------------- ------------------------------------------- Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions 7. have been conducted --- ----------------------------------------------------------------------- Description of the financial instrument, Shire plc American Depositary type of instrument Shares ("ADSs") --- Identification a) code ISIN: US82481R1068 --- -------------------------- ------------------------------------------- Automated disposal of ADSs in relation to the vesting of PSUs referenced in section 6. above. The proceeds of this disposal were used to satisfy personal Nature of the tax liabilities arising from the b) transaction vesting of the PSUs. --- -------------------------- ------------------------------------------- Price(s) Volume(s) --- -------------------------- ---------------------- ------------------- Price(s) and c) volume(s) $ 169.6625 983 --- -------------------------- ------------------ ------------------- d) Aggregated information N/A (single transaction) - Aggregated volume - Price --- -------------------------- ------------------------------------------- e) Date of the December 11, 2018 transaction --- -------------------------- ------------------------------------------- f) Place of the NASDAQ transaction --- -------------------------- ------------------------------------------- Oliver Strawbridge Senior Assistant Company Secretary For further information please contact: Investor Relations Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29 Sun Kim sun.kim@shire.com +1 617 588 8175 Scott Burrows scott.burrows@shire.com +41 41 288 4195 Media Katie Joyce kjoyce@shire.com +1 781 482 2779 NOTES TO EDITORS About Shire Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities who often have few or no other champions. Relentlessly on the edge of what's next, we are serial innovators with a diverse pipeline offering fresh thinking and new hope. Serving patients and partnering with healthcare communities in over 100 countries, we strive to be part of the entire patient journey to enable earlier diagnosis, raise standards of care, accelerate access to treatment, and support patients. Our diverse portfolio of therapeutic areas includes Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics. Championing patients is our call to action - it brings the opportunity - and responsibility - to change people's lives. www.shire.com
(END) Dow Jones Newswires
December 14, 2018 08:15 ET (13:15 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions